stemcell technologies china

STEMCELL Technologies是加拿大规模最大、最成功的生物科技公司，为全球超过120个国家的生命科学领域研发、制造高品质的产品并提供专业服务。STEMCELL由Allen Eaves博士于1993年创立，它的前身是英属哥伦比亚省癌症研究中心的Terry Fox实验室。 STEMCELL的足迹遍布全球各地，95%以上的业务在加拿大境外开展。为了支持全球科学研究的发展，我们雇佣了超过1,200名员工，其中近800人具有硕士或以上学历。在200多人组建的全球销售团队中，40％具有博士学位，他们一直与学术界和工业领域的科学领导者保持稳固的关系。出于对科学的热爱和对高品质的追求，我们利用自己的科学专业知识帮助科学家进行更高效的研究 ，最终组成了一支“科学家帮助科学家”的团队。 2011年，STEMCELL进驻中国，目前在上海和北京均设有办公地点，为全国各个省市提供优质服务。

Beijing Hotgen Biotech Co., Ltd

Hotgen Biotech Co., Ltd was founded in 2005 and is located in the Biomedical Base of Zhongguancun High-Tech Park in Beijing. It is a national-level high-tech company dedicated to developing and manufacturing innovative in-vitro diagnostic (IVD), point-of-care testing (POCT), and biodefense products. Now, Hotgen has four technology platforms: 1. Chemiluminescence Immunoassay CLIA System. ( MQ60 and MQ plus) Test parameters: 1) Cardiac: hs-cTnI, CK-MB, MYO, H-FABP, NT-proBNP, D-Dimer, Lp-PLA2 2) Inflammation Monitoring: CRP, PCT, IL-6 3) Kidney Function: NGAL, Cys-C 4) Tumor Marker: AFP, GP73, AFP-L3, DCP 5) Bone Metabolism: 25-OH-Vitamin D 2. Up-converting Phospher Immunoassay Test System. ( UPT-3A) Test parameters: 1) Cardiac: cTnI, CK-MB, MYO, H-FABP, NT-proBNP, D-Dimer, Lp-PLA2 2) Inflammation Monitoring: CRP, PCT, IL-6 3) Kidney Function: NGAL 4) Liver Function: AFP, GP73 5) Premature Birth: fFN 6) Rheumatoid Arthritis: anti-CCP 3. Colloidal Gold Semi-quantitative Rapid Test PCT, anti-CCP, NT-proBNP, H-FABP, fFN, TP-Ab/IgM, NS1, IgM/IgG, combo NS1+IgM/IgG, Typhoid fever, Malaria Pf/Pv 4. Enzyme-Linked Immunosorbent Assay (ELISA) Test System Anti-CCP, AMH, DCP, CA125, AFP, CEA, PSA, Lp-PLA2, GP73, HBV-LP, HE4

Tecan

At Tecan we are driven to improve people’s lives and health. We do this by empowering our customers to scale healthcare innovation globally from life science to the clinic. We collaborate with our customers in healthcare and the life sciences, from early-stage innovation through project implementation and beyond. We deliver the products, services and solutions that make lab processes and medical procedures precise, reproducible and compliant. This leads to scalable outcomes that are further reaching and ever more valuable to humankind.

BioMarin Pharmaceutical Inc.

Founded in 1997, BioMarin is a global biotechnology company dedicated to transforming lives through genetic discovery. The company develops and commercializes targeted therapies that address the root cause of the genetic conditions that it seeks to treat, helping to better the lives of those struggling with rare genetic disease. BioMarin discoveries have led to eight first or best-in-class commercial treatments and a pipeline of multiple product candidates applying the same science-driven, patient-forward approach to broader group of genetic disorders. The more innovative solutions developed, the more lives BioMarin can impact. Recruitment Fraud Alert Notice Please be aware of fraud or scams from individuals, organizations and/or internet sites claiming to represent BioMarin in recruitment activities. We have an established recruitment process which is required for all posted positions by BioMarin prior to issuing an offer of employment. This BioMarin process requires formal interviews conducted live with personnel representing BioMarin and never requires payments or fees from job applicants. BioMarin does not conduct interviews via texting tools such as RingCentral. In the event you receive a suspicious email message about recruiting on behalf of BioMarin, unless it’s from a BioMarin authorized recruiting partner, do not provide any personal information or pay any fees. Qualified and interested candidates should apply to current openings directly through this BioMarin website. BioMarin accepts no responsibility for any costs or charges incurred as a result of fraudulent activity. If you have lost money or provided your personal identifying information, please contact your bank and report the matter to the FBI via www.ic3.gov. We would also suggest you notify your local police department and monitor your credit. We appreciate your interest in BioMarin & encourage you to visit http://careers.biomarin.com/career-areas to review job opportunities.

BICO

BICO is a leading provider of life science solutions and laboratory automation that enable more efficient development of new treatments with more specificity and less need for animal testing. The company uses bioconvergence as its operating system, combining advanced technologies with biology to streamline and automate workflows within the pharmaceutical and biopharma industries. With 32,000+ instruments installed in over 65 countries, BICO products and solutions are found in more than 3,500 laboratories, including the world’s top 20 pharmaceutical companies, and have been cited in over 11,000 publications. Operating through three business areas – Bioprinting, Biosciences and Bioautomation – the BICO Group strives towards the long-term ambition of enabling the reduction the world’s organ shortage and speeding up drug development to create the future of life-saving treatments. BICO is listed on Mid-Cap, Nasdaq Stockholm under BICO.